课题基金 / 基金详情

Neuroprotective effect of Kampo medicine against brain ischemia and its mode of action

Neuroprotective effect of Kampo medicine against brain ischemia and its mode of action
汉方药对脑缺血的神经保护作用及其作用机制
批准号:
16590556
负责人:
SHIMADA Yutaka
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

SHIMADA Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
以前,我们已经revealed that chotosan (Diao-teng-san), a Kampo formula,is effective on vascular dementia clinically, and the hooks and stems of Uncaria sinensis,一个医疗植物comprising chotosan,has a neuroproteve effect in vitro. For the purpose of clarifying their effects in vivo,我们investigated whether the oral administration of chotosan extract (CSE) or Uncaria sinensisextract (USE) reduces delayed neuronal death of pyramidal cells in the hippocampus followingischemia/reperfusion (i/rp) in gerbils. CSE or USE dissolved in drinking water and provided tothe gerbils ad libitum from 7 days prior to i/rp until 7 days after i/rp. It was found that CSE-orUSE-treatments significantly reduced pyramidal cell death in the hippocampal CA1 region at 7 daysafter i/rp. Lipid peroxide (LPO) and nitrite (no_2 ^-)/nitrate (no_3 ^-) levels of the hippocampus at48hr after i/rp in the CSE- or USE-treated groups were significantly lower than those of control.Superoxide anion (o_2 ^-) and hydroxyl radical (HO) scavenging activities in both the hippocampusand cortex without i/rp, and also at 3 hours and 7 days after i/rp,were enhanced by the administration of CSE or USE. Administrations of CSE or USE without i/rpprocedure enhanced catalase (CAT) activity but superoxide dismutase (SOD) and glutathioneperoxidase (GSH-Px) activities in the both the hippocampus and cortex. CSE elevated CAT activity in thehippocampus at 7 days and that in the cortex at 3 hours after i/rp. USE raised CAT activity in boththe hippocampus and cortex at 3小时7天after i/rp. These results suggest that the oraladministrations of CSE and USE provide a protective effect against transient ischemi -induceddelayed neuronal death by reducing oxidative damage to neuronsand one of the mechanisms may be their增强猫activity in the brain的效果。
英文摘要
Previously, we have revealed that chotosan (Diao-teng-san), a Kampo formula, is effective on vascular dementia clinically, and the hooks and stems of Uncaria sinensis, a medicinal plant comprising chotosan, has a neuroprotective effect in vitro. For the purpose of clarifying their effects in vivo, we investigated whether the oral administration of chotosan extract (CSE) or Uncaria sinensis extract (USE) reduces delayed neuronal death of pyramidal cells in the hippocampus following ischemia/reperfusion (i/rp) in gerbils. CSE or USE were dissolved in drinking water and provided to the gerbils ad libitum from 7 days prior to i/rp until 7 days after i/rp. It was found that CSE-or USE-treatments significantly reduced pyramidal cell death in the hippocampal CA1 region at 7 days after i/rp. Lipid peroxide (LPO) and nitrite (NO_2^-)/nitrate (NO_3^-) levels of the hippocampus at 48 hr after i/rp in the CSE- or USE-treated groups were significantly lower than those of control. Superoxide anion (O_2^-・) and hydroxyl radical (HO・) scavenging activities in both the hippocampus and cortex without i/rp, and also at 3 hours and 7 days after i/rp, were enhanced by the administration of CSE or USE. Administrations of CSE or USE without i/rp procedure enhanced catalase (CAT) activity but not superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities in both the hippocampus and cortex. CSE elevated CAT activity in the hippocampus at 7 days and that in the cortex at 3 hours after i/rp. USE raised CAT activity in both the hippocampus and cortex at 3 hours and 7 days after i/rp. These results suggest that the oral administrations of CSE and USE provide a protective effect against transient ischemia-induced delayed neuronal death by reducing oxidative damage to neurons, and one of the mechanisms may be their enhancing effect on CAT activity in the brain.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Chotosan and cerebrovascular disorders : clinical and experimental studies
Chotosan 和脑血管疾病:临床和实验研究
DOI: --
发表时间: 2006
期刊: Journal of Traditional Medicines Vol.23
影响因子: --
作者: [Yutaka Shimada, et al.]
通讯作者: et al.
DOI: 10.1016/j.phymed.2003.04.001
发表时间: 2004-09-01
期刊: PHYTOMEDICINE
影响因子: 7.9
作者: [Yokoyama, K, Shimada, Y, Terasawa, K]
通讯作者: Terasawa, K
DOI: 10.1016/j.jep.2004.08.018
发表时间: 2004-12-01
期刊: JOURNAL OF ETHNOPHARMACOLOGY
影响因子: 5.4
作者: [Yokoyama, K, Shimada, Y, Terasawa, K]
通讯作者: Terasawa, K
Chotosan and cerebrovascular disorders : clinical and experimental studies.
Chotosan 和脑血管疾病:临床和实验研究。
DOI: --
发表时间: 2006
期刊: Journal of Traditional Medicines 23巻
影响因子: --
作者: [Yutaka Shimada, Hirozo Goto, Katsutoshi Terasawa]
通讯作者: Katsutoshi Terasawa
Research on the treatment of esophageal cancer with anti-human fibroblast growth factor receptor like-1
  • 批准号:
    26293302
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.4万
  • 财政年份:
    2014
  • 负责人:
    SHIMADA Yutaka
  • 依托单位:
Detection of gastrointestinal cancer biomarkers by next-generation mass spectrometry and comprehensive gene expression analysis
Protective effect of Kampo medicine on vascular endothelial functionin patients with metabolic syndrome
  • 批准号:
    22590649
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.66万
  • 财政年份:
    2010
  • 负责人:
    SHIMADA Yutaka
  • 依托单位:
Research for the establishment of pluripotent stem cells from normal human culture cells and tissue engineering
  • 批准号:
    22659228
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.04万
  • 财政年份:
    2010
  • 负责人:
    SHIMADA Yutaka
  • 依托单位:
海外基金